TET Systems and AMC/STW enter into an assignment agreement

04-Dec-2009 - TET Systems Holding (TSH), the Academic Medical Center (AMC), and Technology Foundation STW announced that they have entered into an assignment agreement. Scientists at the AMC have previously developed a novel series of reverse transactivators with improved properties. Under the terms of the ...

Michael J. Fox Foundation Awards $2 Million Grant from Merck Serono to Research Projects on Parkinson's Disease

Five Research Teams Selected to Receive Funding for Preclinical and

16-Oct-2008 - The Michael J. Fox Foundation for Parkinson's Research (MJFF) awarded a total of$2 million to five research teams to speed development of effective therapies for the under-addressed cognitive and mood-related symptoms of Parkinson's disease (PD). The award was made possible by leadership funding ...

New strategy for treating allergic disorders

02-Aug-2007 - Oral intake of allergens or auto-antigens via the lactic acid bacterium Lactococcus lactis might be a new strategy for treating various kinds of auto-immune and allergic disorders. VIB researchers associated with Ghent University, in collaboration with the Academic Medical Center (AMC) in ...

Organon and the Academic Medical Center jointly develop novel treatment of rheumatoid arthritis

12-Jan-2007 - Organon announced a research collaboration with the Academic Medical Center (AMC) on a novel therapy for the treatment of rheumatoid arthritis. Organon plans to continue research and development aiming at clinical application of the AMC finding for treatment of rheumatoid arthritis and possible ...